Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Biotech
Have Moderna, Merck kicked off a 'personalized med revolution'?
Experts told Fierce that intismeran's phase 3 win had boosted prospects for other biopharmas exploring personalized mRNA treatments for cancer.
Marissa Russo
Sep 11, 2026 9:00am
Frazier Life Sciences nets $1.1B in long-running biotech fund
Sep 10, 2026 9:44am
A year after Big Pharma’s pull-back from the UK, what’s changed?
Sep 4, 2026 10:00am
Merck-Moderna vaccine data spur talk of Keytruda-like impact
Aug 20, 2026 9:25am
Merck-Moderna cancer vax slows recurrence in ph. 3 trial
Aug 19, 2026 6:45am
Merck and Sarah Cannon team up for oncology trial efficiency
Aug 18, 2026 4:00pm
